Catalyst Wire Dossier Catalyst Wire Dossier

L-DOPA 100 mg

Levodopa
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for L-DOPA 100 mg, covering 2023-06-01 to 2023-06-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD [Phase 4]

See pricing